Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Features of Patients With Treatment-Resistant Depression

NCT03134066 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03134066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03134066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Features of Patients With Treatment-Resistant Depression
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
September 30, 2016
Completion date
January 17, 2018
Enrollment
13 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression